4
Changes in Ownership
Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-20-019502
Chief Executive Officer bought 4,300 shares at $3.49 ($15,007)
From the SEC's structured data for this filing
Trades in this filing
Cohen Yuval · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-03-17 | Purchase : show line 1 in the form | +4,300 | $3.49 | $15,007 | 71,090 | D |
| Open-market purchases · 4,300 sh · avg $3.49 · $15,007 | ||||||
Loading xslF345X03/doc4.xml…